In a landmark and industry-defining partnership, the Iaso NeuroImpact Fund announced a longterm collaboration with the Epilepsy Foundation around mission-driven investments. See here for the press release.

The double bottomline fund’s goal is to support the most impactful innovations in the neurosciences and improve the lives of people with neurological and psychiatric disorders by finding much needed cures. 

“This collaboration represents an unprecedented opportunity to engage a wider spectrum of investors in driving tangible outcomes for people living with epilepsy,” said Wasim Malik, managing partner, Iaso Ventures. “The Iaso NeuroImpact Fund will not only benefit those affected by debilitating neurological disorders but also offer investors a unique opportunity to make a meaningful difference while reaping market-leading financial returns.”